PharmaRoth Labs (PharmaRoth Labs) Additional Paid-In Capital : $0.27 Mil(As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Additional Paid-In Capital?

PharmaRoth Labs's quarterly additional paid-in capital stayed the same from Sep. 2010 ($0.11 Mil) to Dec. 2010 ($0.11 Mil) but then increased from Dec. 2010 ($0.11 Mil) to Mar. 2011 ($0.27 Mil).

PharmaRoth Labs's annual additional paid-in capital declined from Jun. 2008 ($0.03 Mil) to Jun. 2009 ($-0.09 Mil) but then stayed the same from Jun. 2009 ($-0.09 Mil) to Jun. 2010 ($-0.09 Mil).

PharmaRoth Labs Additional Paid-In Capital Historical Data

The historical data trend for PharmaRoth Labs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Additional Paid-In Capital Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Additional Paid-In Capital

0.03

-0.09

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Additional Paid-In Capital	Get a 7-Day Free Trial											0.01	-0.09	0.11	0.11	0.27

PharmaRoth Labs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

PharmaRoth Labs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022